Pune-based Gennova Biopharmaceuticals which received regulatory approval for clinical trials of its indigenous mRNA vaccine four months ago will start human trials this month, a top company executive said.

Drugs Controller General of India V.G. Somani allowed Gennova, a subsidiary of Pune-based Emcure Pharmaceuticals, to conduct phase 1 and 2 clinical trials in December. However, the trial got delayed after the regulator asked the firm to redo an animal toxicity study that had been conducted in the US.

Leave a Reply

Your email address will not be published. Required fields are marked *